Ironwood Pharmaceuticals, Inc. (IRWD) Documents: SEC Filings, Investor Presentations & Press Releases

Ironwood Pharmaceuticals, Inc. (IRWD) documents, SEC filings and the IR site together: 89 documents, newest first; latest 2026-08-06. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-06TranscriptQ2 FY26 earnings call transcript
2026-08-068-KForm 8-K, Item 2.02 results
2026-08-0610-QForm 10-Q for the quarter ended Jun 30
2026-06-188-KForm 8-K, Item 5.02
2026-06-158-KForm 8-K, Item 8.01
2026-05-218-KForm 8-K/A, Item 5.02
2026-05-138-KForm 8-K, Item 5.02
2026-05-078-KForm 8-K, Item 2.02 results
2026-05-0710-QForm 10-Q for the quarter ended Mar 31
2026-05-06DeckQ1 2026 Investor Update
2026-04-28ProxyDefinitive proxy statement
2026-03-118-KForm 8-K, Item 8.01
2026-02-2610-KAnnual report on Form 10-K, FY25
2026-02-258-KForm 8-K, Item 2.02 results
2026-02-24DeckQ4 and FY 2025 Investor Update
2026-01-028-KForm 8-K, Item 2.02 results
2025-12-238-KForm 8-K, Item 1.01
2025-11-268-KForm 8-K, Item 8.01
2025-11-108-KForm 8-K, Item 2.02 results
2025-11-1010-QForm 10-Q for the quarter ended Sep 30
2025-11-07DeckQ3 2025 Investor Update
2025-10-108-KForm 8-K, Item 5.02
2025-09-038-KForm 8-K, Item 8.01
2025-08-1110-QForm 10-Q for the quarter ended Jun 30
2025-08-07DeckQ2 2025 Investor Update
2025-08-078-KForm 8-K, Item 2.02 results
2025-07-108-KForm 8-K, Item 4.01
2025-06-128-KForm 8-K, Item 5.07
2025-06-038-KForm 8-K, Item 3.01
2025-05-1210-QForm 10-Q for the quarter ended Mar 31
2025-05-078-KForm 8-K, Item 2.02 results
2025-04-28ProxyDefinitive proxy statement
2025-04-258-KForm 8-K, Item 2.02 results
2025-04-148-KForm 8-K, Item 8.01
2025-03-3110-KAnnual report on Form 10-K, FY24
2025-03-278-KForm 8-K, Item 3.01
2025-02-278-KForm 8-K, Item 2.02 results
2025-01-298-KForm 8-K, Item 2.05
2024-12-058-KForm 8-K, Item 5.02
2024-11-128-KForm 8-K, Item 5.02

IRWD overview · IRWD earnings · IRWD financials · IRWD KPIs · IRWD ownership · IRWD peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.